New CHF drug shown to ease breathing distress among hospitalized patients.
Natrecor (nesiritide) is targeted to acute decompensating CHF patients.
D009320:Atrial Natriuretic Factor / Q000009:adverse effects / Q000191:economics / Q000627:therapeutic use*; D002316:Cardiotonic Agents / Q000009:adverse effects / Q000191:economics / Q000627:therapeutic use*; D016527:Drug Costs; D004417:Dyspnea / Q000188:drug therapy*; D006333:Heart Failure / Q000188:drug therapy* / Q000503:physiopathology; D006760:Hospitalization; D006801:Humans; D007022:Hypotension / Q000139:chemically induced; D020097:Natriuretic Peptide, Brain; D014481:United States
D002316:Cardiotonic Agents; D020097:Natriuretic Peptide, Brain; D009320:Atrial Natriuretic Factor